Filter posts

Biotech Sector Performance Update 1H 2010

In my last update back in April, the broadest Biotech index (the 125 company Nasdaq …

2010 BIO Business Forum Partnering Results

2010 BIO Business Forum in Chicago was a huge success last week. We hit record …

1Q 2010 - All Time High for the BTK

The first quarter of 2010 saw the Amex Biotech Index (BTK) hit another all time …

FOPO - A Late Stage Financing Tool

The follow-on public offering (FOPO) market has been strong for biotech since early last year, …

Is P/E Compression Making Biotech a Bargin?

For the first time in biotech history, price to earnings multiples (P/E based on next …

Posts from the 9th Annual BIO Winhover & Pharmaceutical Strategic Outlook Conference (Feb 2010)

Did you miss a panel at the BIO Windhover/PSO Conference in New York? Here are …

VC Fundraising Back to 2005 Levels

Is Venture Capital “holding up” for US biotech? Although there is a silver lining that …

Posts from the 12th Annual BIO CEO & Investor Conference in New York (Feb 2010)

I created a new page on the blog (now called the “CONFERENCES” tab) where key …

BTK – A Decade of Change

Do you ever wonder what is really behind the often quoted BTK index (“NYSE Arca …

Many Biotechs Still Operating at Low Cash Levels

The percentage of public biotech companies that still operate with less than a year of …